Thu, January 6, 2022
Wed, January 5, 2022
Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021

Oren Livnat Maintained (XERS) at Strong Buy with Increased Target to $5.4 on, Dec 31st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-5-4-on-dec-31st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy with Increased Target from $4.25 to $5.4 on, Dec 31st, 2021.

Oren, nor any peers, have made any analyst calls on XERS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources